Robert Henry Perry
Robert Henry Perry publishes mostly in Molecular Biology, Cellular and Molecular Neuroscience and Physiology, on topics such as Alzheimer's disease research and treatments, Cholinesterase and Neurodegenerative Diseases and Nicotinic Acetylcholine Receptors Study.
- World rank
- #101,285 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #8,907 of 367,258
- Works
- 185
- Citations
- 21k
- Citations per work
- 113.8
What does Robert Henry Perry research?
Robert Henry Perry's work is mostly in Medicine (37%), Biochemistry, Genetics and Molecular Biology (16%), Neuroscience (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6937.3%
- Medicine6937.3%
- Everything else6133.0%
- Life Sciences5529.7%
- Biochemistry, Genetics and Molecular Biology3016.2%
- Neuroscience2513.5%
- 1Molecular Biology16% of their works
- 2Cellular and Molecular Neuroscience14% of their works
- 3Physiology12% of their works
- 4Neurology10% of their works
- 5Pharmacology9% of their works
- 6Psychiatry and Mental health6% of their works
Research topics
- Alzheimer's disease research and treatments
- Cholinesterase and Neurodegenerative Diseases
- Nicotinic Acetylcholine Receptors Study
- Neuroscience and Neuropharmacology Research
- Parkinson's Disease Mechanisms and Treatments
- Dementia and Cognitive Impairment Research
- Receptor Mechanisms and Signaling
- Memory and Neural Mechanisms
Which keywords describe Robert Henry Perry's research?
The keywords of their largest research topics: Alzheimer's Disease, Neurodegeneration, Oxidative Stress, Pharmacology, Crystal Structure, Amyloid Hypothesis, Tau Pathology and Acetylcholinesterase.
- Hippocampus
- G-Protein-Coupled Receptors
- Dementia
- Parkinson's Disease
- Nicotinic Acetylcholine Receptors
- Neuronal Signaling
- Acetylcholinesterase
- Amyloid Hypothesis
- Pharmacology
- Neurodegeneration
- Alzheimer's Disease
- Oxidative Stress
- Crystal Structure
- Tau Pathology
- Cholinesterase Inhibitors
- Neurotransmission
- Synaptic Plasticity
- a-Synuclein
- Mild Cognitive Impairment
- Signal Transduction
- Memory
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Alzheimer's Disease1033 topics
- Neurodegeneration842 topics
- Oxidative Stress842 topics
- Pharmacology632 topics
- Crystal Structure532 topics
- Amyloid Hypothesis521 topic
- Tau Pathology521 topic
- Acetylcholinesterase471 topic
- Cholinesterase Inhibitors471 topic
- Neuronal Signaling371 topic
- Neurotransmission371 topic
- Nicotinic Acetylcholine Receptors371 topic
- Synaptic Plasticity371 topic
- Parkinson's Disease321 topic
- a-Synuclein321 topic
- Dementia191 topic
- Mild Cognitive Impairment191 topic
- G-Protein-Coupled Receptors161 topic
- Signal Transduction161 topic
- Hippocampus131 topic
- Memory131 topic
Where does Robert Henry Perry work?
Robert Henry Perry's main affiliation in the publication record is North Tyneside General Hospital, United Kingdom.
How many publications and citations does Robert Henry Perry have?
OpenAlex counts 185 works and 21,060 citations for Robert Henry Perry, an h-index of 69, ranking #101,285 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Robert Henry Perry. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.